|
Name |
paecilin M
|
Molecular Formula | C32H32O15 | |
IUPAC Name* |
4-hydroxy-4-[5-hydroxy-6-[5-hydroxy-2-methoxycarbonyl-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromen-6-yl]-2-methoxycarbonyl-4-oxo-3H-chromen-2-yl]-3-methylbutanoicacid
|
|
SMILES |
COC(=O)C1(C(O)C(C)CC(=O)O)CC(=O)c2c(ccc(-c3ccc4c(c3O)C(=O)CC(C(=O)OC)(C3OC(=O)CC3C)O4)c2O)O1
|
|
InChI |
InChI=1S/C32H32O15/c1-13(9-21(35)36)27(40)31(29(41)43-3)11-17(33)23-19(46-31)7-5-15(25(23)38)16-6-8-20-24(26(16)39)18(34)12-32(47-20,30(42)44-4)28-14(2)10-22(37)45-28/h5-8,13-14,27-28,38-40H,9-12H2,1-4H3,(H,35,36)/t13-,14-,27+,28+,31-,32-/m0/s1
|
|
InChIKey |
SOKXGWCHBMJPLI-PMHDQPJQSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 656.59 | ALogp: | 1.9 |
HBD: | 4 | HBA: | 14 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 229.5 | Aromatic Rings: | 5 |
Heavy Atoms: | 47 | QED Weighted: | 0.236 |
Caco-2 Permeability: | -5.85 | MDCK Permeability: | 0.00000632 |
Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0.065 |
Human Intestinal Absorption (HIA): | 0.933 | 20% Bioavailability (F20%): | 0.023 |
30% Bioavailability (F30%): | 0.94 |
Blood-Brain-Barrier Penetration (BBB): | 0.01 | Plasma Protein Binding (PPB): | 84.55% |
Volume Distribution (VD): | 0.327 | Fu: | 4.81% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.314 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.792 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.15 |
CYP3A4-inhibitor: | 0.374 | CYP3A4-substrate: | 0.313 |
Clearance (CL): | 13.091 | Half-life (T1/2): | 0.34 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.799 |
Drug-inuced Liver Injury (DILI): | 0.979 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.867 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.01 | Carcinogencity: | 0.106 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.006 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005735 | 0.904 | D0T5XN | 0.289 | ||||
ENC005736 | 0.884 | D01XWG | 0.271 | ||||
ENC005727 | 0.797 | D07IPB | 0.268 | ||||
ENC005729 | 0.725 | D0C9XJ | 0.266 | ||||
ENC005732 | 0.702 | D07VLY | 0.266 | ||||
ENC005733 | 0.698 | D01XDL | 0.264 | ||||
ENC003347 | 0.673 | D0T8EH | 0.248 | ||||
ENC005885 | 0.669 | D01UBX | 0.243 | ||||
ENC005737 | 0.631 | D0N1FS | 0.235 | ||||
ENC003348 | 0.615 | D0Q0PR | 0.230 |